Docosahexaenoic Acid Promotes Dopaminergic Differentiation in Induced Pluripotent Stem Cells and Inhibits Teratoma Formation in Rats With Parkinson-Like Pathology

doi:10.3727/096368911X580572

CNU IR > Pharmacy and Science > Dept. of Pharmacy > Periodical Articles > Item 310902800/27708

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/27708

Title:	Docosahexaenoic Acid Promotes Dopaminergic Differentiation in Induced Pluripotent Stem Cells and Inhibits Teratoma Formation in Rats With Parkinson-Like Pathology
Authors:	Chang, Yuh-Lih Chen, Shih-Jen Kao, Chung-Lan Hung, Shih-Chieh Ding, Dah-Ching Yu, Cheng-Chia Chen, Yi-Jen Ku, Hung-Hai Lin, Chin-Po Lee, Kun-Hsiung Chen, Yu-Chih Wang, Jhi-Joung Hsu, Chuan-Chih Chen, Liang-Kung Li, Hsin-Yang Chiou, Shih-Hwa
Contributors:	藥學系休閒保健管理系
Keywords:	Parkinson'S Disease Dopamine Induced Pluripotent Stem Cells (Ips) Dopaminergic Neurons Docosahexaenoic Acid (Dha) 3T-Mri
Date:	2012-01
Issue Date:	2014-03-21 16:18:21 (UTC+8)
Publisher:	Cognizant Communication Corp
Abstract:	Parkinson's disease (PD) is a neurodegenerative disorder characterized by the degeneration of dopaminergic (DA) neurons in the midbrain. Induced pluripotent stem (iPS) cells have shown potential for differentiation and may become a resource of functional neurons for the treatment of PD. However, teratoma formation is a major concern for transplantation-based therapies. This study examined whether functional neurons could be efficiently generated from iPS cells using a five-step induction procedure combined with docosahexaenoic acid (DHA) treatment. We demonstrated that DHA, a ligand for the RXR/Nurr1 heterodimer, significantly activated expression of the Nurr1 gene and the Nurr1-related pathway in iPS cells. DHA treatment facilitated iPS differentiation into tyrosine hydroxylase (TH)-positive neurons in vitro and in vivo and functionally increased dopamine release in transplanted grafts in PD-like animals. Furthermore, DHA dramatically upregulated the endogenous expression levels of neuroprotective genes (Bcl-2, Bcl-xl, brain-derived neurotrophic factor, and glial cell-derived neurotrophic factor) and protected against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced apoptosis in iPS-derived neuronal precursor cells. DHA-treated iPS cells significantly improved the behavior of 6-hydroxydopamine (6-OHDA)-treated PD-like rats compared to control or eicosapentaenoic acid-treated group. Importantly, the in vivo experiment suggests that DHA induces the differentiation of functional dopaminergic precursors and improves the abnormal behavior of 6-OHDA-treated PD-like rats by 4 months after transplantation. Furthermore, we found that DHA treatment in iPS cell-grafted rats significantly downregulated the mRNA expression of embryonic stem cell-specific genes (Oct-4 and c-Myc) in the graft and effectively blocked teratoma formation. Importantly, 3 Tesla-magnetic resonance imaging and ex vivo green fluorescence protein imaging revealed that no teratomas were present in transplanted grafts of DHA-treated iPS-derived DA neurons 4 months after implantation. Therefore, our data suggest that DHA plays a crucial role in iPS differentiation into functional DA neurons and that this approach could provide a novel therapeutic approach for PD treatment.
Relation:	Cell Transplantation, v.21 n.1 pp.313-332(20)
Appears in Collections:	[Dept. of Pharmacy] Periodical Articles [Dept. of Recreation and Health-Care Management] Periodical Articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	2081	View/Open

Loading...